- Home
- NIM vs TELA Comparison
NIM vs TELA Comparison
Compare NIM & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- TELA
- Stock Information
- Founded
- NIM 1992
- TELA 2012
- Country
- NIM United States
- TELA United States
- Employees
- NIM N/A
- TELA N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- TELA Medical/Dental Instruments
- Sector
- NIM Finance
- TELA Health Care
- Exchange
- NIM Nasdaq
- TELA Nasdaq
- Market Cap
- NIM 112.0M
- TELA 104.0M
- IPO Year
- NIM N/A
- TELA 2019
- Fundamental
- Price
- NIM $9.04
- TELA $2.72
- Analyst Decision
- NIM
- TELA Strong Buy
- Analyst Count
- NIM 0
- TELA 4
- Target Price
- NIM N/A
- TELA $9.25
- AVG Volume (30 Days)
- NIM 35.4K
- TELA 167.6K
- Earning Date
- NIM 01-01-0001
- TELA 03-20-2025
- Dividend Yield
- NIM 3.46%
- TELA N/A
- EPS Growth
- NIM N/A
- TELA N/A
- EPS
- NIM N/A
- TELA N/A
- Revenue
- NIM N/A
- TELA $68,649,000.00
- Revenue This Year
- NIM N/A
- TELA $30.39
- Revenue Next Year
- NIM N/A
- TELA $25.51
- P/E Ratio
- NIM N/A
- TELA N/A
- Revenue Growth
- NIM N/A
- TELA 29.34
- 52 Week Low
- NIM $8.28
- TELA $2.30
- 52 Week High
- NIM $9.74
- TELA $7.52
- Technical
- Relative Strength Index (RSI)
- NIM 66.26
- TELA 48.25
- Support Level
- NIM $8.88
- TELA $2.56
- Resistance Level
- NIM $9.03
- TELA $2.87
- Average True Range (ATR)
- NIM 0.10
- TELA 0.17
- MACD
- NIM 0.02
- TELA 0.01
- Stochastic Oscillator
- NIM 74.29
- TELA 56.76
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.